Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.

Journal

Haematologica

ISSN: 1592-8721

Titre abrégé: Haematologica

Pays: Italy

ID NLM: 0417435

Informations de publication

Date de publication:
03 Aug 2023

Historique:

received: 05 08 2022

medline: 3 8 2023

pubmed: 3 8 2023

entrez: 3 8 2023

Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2022.281780 PMID: 37534517

pubmed: 37534517

doi: 10.3324/haematol.2022.281780

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Auteurs

Austin G Kulasekararaj (AG)

King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London.

Anna-Elina Lehtinen (AE)

Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki.

Shreyans Gandhi (S)

King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London.

University of Ulm, Institute of Transfusion Medicine, and Institute of Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm.

Gabor Mikala (G)

Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest.

Petra Muus (P)

King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London, UK; St. James's University Hospital, Leeds.